Advanced Search
Contact | Corporate | Help

Daily news email for June 06, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
President of Israeli Weizmann Institute Meets with Representatives of the Health Axis Europe ...

Omixon Releases Omixon Target for Next Generation Sequencing Data Analysis for Diagnostics

Lophius Biosciences Completes Necessary Regulatory Milestones with EN ISO 13485 Certification ...

Antisense Pharma Presents Trabedersen Phase I/II Complete Data at ASCO

Joint Development of a Novel Lyophilized Dual Chamber Prefillable Syringe System

 BioSpace
Dr. Reddy's Laboratories Ltd., Merck Serono in Pact to Develop Biotech Drug Copies

Untreatable Gonorrhoea Spreading Around World, World Health Organization Reveals

FDA Seeks Data on Delivery Method for Amylin Pharmaceuticals, Inc. Drug

Amylin Pharmaceuticals, Inc. Preps for 2nd Round After Bids Boost Appeal

Bigger Waist Tied to Increased Risk of Diabetes, Study

BioSpace - Breaking News
CalAsia Pharmaceuticals, Inc. , a Structure-Based Drug-Discovery Company; Seeks Corporate Partners to Complete the Pre-Clinical Development of Its Proprietary HSP90 Inhibitor Series

Hyperion Therapeutics Glycerol Phenylbutyrate Meets Primary Endpoint in Phase II Study in Episodic Hepatic Encephalopathy

NovaBay Pharmaceuticals, Inc. Announces Successful End-of-Phase 2a FDA Meeting for Dermatology Program

Verva Pharmaceuticals Announces Results of Successful VVP808-002 Phase 2 Clinical Trial in Type 2 Diabetes and Outcome of Annual General Meeting

Celgene International Srl Advances ABRAXANE (nab-paclitaxel) Development in Difficult-to-Treat Cancers

Biotech News - Business Wire
Scientific American to Host BIO International Convention Super Session to Release 4th Annual Worldview Report and Scorecard Highlighting Emerging Markets

MedCap Advisors Moves Offices to Harvard Square

Partnering for Global Impact® 2012 Awards Socially Responsible Initiatives with Fidelity Future Impact Prize

European High-Acuity Information System Market to See Significant Downturn in 2012 and 2013

Sony DADC BioSciences walks away with Best New Company 2012 Award at the European Life Science Awards

 Biotech News - PR Newswire
RAPID-PsA study showed that certolizumab pegol improved the signs and symptoms of psoriatic arthritis

Rhythm Initiates Phase 2 Clinical Trial of Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis

IDEV Technologies étoffe son équipe commerciale

MO BIO Laboratories, Inc. Launches the PowerMag Soil and Microbial DNA Isolation Kits

Cryo-Save geht eine Langzeit-Kooperation mit der Katholischen "Holy Heart" Universität ein
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Marina Biotech Slashes 90 Percent of Workforce

Bristol-Myers Squibb Forms the International Immuno-Oncology Network

23andMe Patent Creates Concerns with Customers

China Poised to Boost Biotech

User Fee Packages Win Congressional Approval

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
NovaSom, Inc. Launches AccuSom Deliver

New Healthcare Products for Safer, More Efficient Care Featured at National Event

Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Knotless Tissue Closure Device

Research and Markets: Spondylitis Global Clinical Trials Review, H1, 2012

ProFibrix schrijft eerste patiënten in voor cruciale fase III-studie met FibrocapsTM

 Clinical Trials - PR Newswire
PacificGMP and Vasgene Therapeutics Announce Successful Manufacture of Recombinant Fusion Protein for Phase 1 Clinical Trial

Step Study Results Demonstrate Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation at 24 Months

New Analysis of Phase III Trials Shows Gout Patients with Chronic Kidney Disease at Any Stage Responded to KRYSTEXXA® Presented in Oral Session at EULAR 2012

Investors join Inclinix, Inc. with PMG Research Inc. to create global clinical trial site and patient recruitment organization -- Inclinix-PMG Holdings, Inc.

Sapio Sciences Announces Exemplar Biomarker Discovery LIMS for Personalized Medicine

 CNN Top Stories
275-lb. pet cougar escapes, kills dog

Charlize's creepy charity date

Miley Cyrus, Liam Hemsworth engaged

Opinion: Why watch video of killings

Hand, foot sent to schools in Canada
Contract Pharma
PacificGMP Manufactures Fusion Protein for Vasgene

Avrio Appoints Quality/Regulatory Affairs VP

Catalent Increases Sterile Fill/Finish Capacity

GEA Pharma Secures Penn Pharma Order

Dr. Reddy's, Merck Serono in Biosimilars Pact

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

 FDA News - Business Wire
Samenvatting: FDA geeft toestemming voor Erchonia's Zerona laser voor reductie armomtrek

Resumen: La FDA autoriza el láser Zerona de Erchonia para la reducción no invasiva del volumen de los brazos

Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds from the State of Texas

NinePoint Medical Receives European CE Mark Approval and ISO Certification for NvisionVLE Imaging System

Hyperion Therapeutics Glycerol Phenylbutyrate Meets Primary Endpoint in Phase II Study in Episodic Hepatic Encephalopathy
FDA Press Releases
FDA warns consumers about counterfeit version of Teva's Adderall

FDA issues alert on Reumofan Plus

U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC

FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions

FDA approves generic versions of blood thinner Plavix

 FDA Vaccines, Blood and Biologics - What's New
Procleix Ultrio Plus Assay

Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

 FierceBiotech
J&J contributes to PhaseBio's $23M B-round expansion

Drug developers extol human data in brain cancer fight

Astellas trumpets rapid growth as it moves into $150M U.S. campus

Chinese scientist convicted of stealing Merck's experimental drugs

Special report: Stem cell research advances by fits and starts
FierceBiotech IT
Complete Genomics axes 55 staffers

Roche re-enlists software for personalized medicine research

23andMe stakes a claim on Parkinson's gene

BGI and Big Pharma probe trigger of liver cancer

Univ. of Texas group speeds up drug discovery with supercomputers

 FierceBiotech Research
New peptide compound triggers enhanced tumor cell death

Stem cell research advances in fits and starts

Embyronic stem cells treat neuropathic pain in preclinical success

Scientists decipher how T cells hunt down infection

CIRM stem cell funding to shift toward the clinical development side

 FiercePharma
Geneva workers propose scaleback at Merck Serono HQ

U.K. pharma balks at value-based pricing ideas

House would cut $16 million from FDA funding

Shelves still bare of Tylenol products, stores lament recalls

Pradaxa leads FDA MedWatch list of fatalities
FiercePharma Manufacturing
Track and trace details need to be worked out in FDA reauthorization

Fake Adderall surfaces as Congress turns attention to track and trace

Another Indian drugmaker expanding in Nigeria

Ex-CEO of devicemaker gets probation for lying about imports

China may blacklist substandard drug manufacturers

 FierceVaccines
Taking the pain out of shots

Oral TB vax could cut treatment time

Making safer and better shots

Tumor necrosis factor supports cancer vaccine

Bionor's new HIV vaccine moves into clinical trials

 Health News - BizJournals.com
Via Christi plan to convert to private rooms starts with $10M project at East Harry

BDSI receives upgrade from The Street

Catalent Pharma expands local manufacturing capacity

Schmidt Wallace will seek reversal of HealthSouth decision

Summer@Highland says college startups more adept than ever
Health News - CNBC
Vaccines for U.S. children may not be properly stored: study

Food meets pharma as Nestle fights for health claims

Dow leaps, is on track for a second day of gains

Antares transfers listing to Nasdaq from NYSE Amex

Pfizer job cuts highlight Irish exposure to patent expiries

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Late-Stage Study Shows Benefits of Abbott's Humira Against Nonradiographic axSpA

Janssen's Stelara Improves Active Psoriatic Arthritis in Phase III Study

Multiplicom Wins $260K to Develop Maternal Blood Test for Fetal Aneuploidies

Phase III Data Shows Novartis Canakinumab Enables SJIA Patients to Remain Symptom Free

PhaseBio Raises $23M to Continue Clinical Development of Polymer-Fused Diabetes Drugs
Marketwire - Pharma and Biotech
Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board

Pyng Medical Corp. Extends Previously Announced $500,000 Non-Brokered Private Placement

Elsevier Business Intelligence (EBI) to Host 'Investment in Innovation (IN3) Medical Device 360° Summit - San Francisco', October 15-17, 2012

Declining R&D Budgets Drive Outsourcing of Drug Discovery Functions

The Medicines Company Prices $225 Million of Convertible Notes

 MassBio News
Breaking: MassBio Applauds House for Passage of PDUFA

Charlton is BioReady

Visit the MA Pavilion @ BIO 2012

MassBio Competing in Social Madness Challenge

Boston Biotech Industry Takes Center Stage at the 2012 BIO International Convention

Medical Pharma - PR Newswire
Calgary Scientific Expands Its FDA-Cleared List, Now Adding Vessel Analysis Capabilities to the Growing List of Advanced Clinical Tools Cleared for Diagnostic Use

DMC Gets Perfect Score in Leapfrog Group's Safety Score Rankings

Orthodontic Treatment combined with Orthognathic Surgery Bring Dramatic Positive Results in Patients with Severe Jaw Problems

MDHI Talks Distribution, Product Feature Advantages, New Large Customers, Toxic Debt Retirement, and Movement towards Profitability

Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Dallas-Fort Worth Teens at Risk; School Nurses Rally Community in Response
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

 New York Times- Biotechnology
Study Backs Continuous Prostate Cancer Treatment

DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances
New York Times- Pharmaceuticals
Drug Maker Endo Gets Input in House Bill on Generics

CITY ROOM; 14 Are Accused in Operation Of Open-Air Drug Markets

Game Is Designed to Help Doctors to Spot Drug Abuse

Glaxo Said to Aim to Replace Human Genome's Board

A New Class of Cancer Drugs May Be Less Toxic

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India

R&D and commercial work together to design trials, says DIA

Patheon launches CMC consultancy in face of restructuring plans
Pharma News - Business Wire
Celgene Advances ABRAXANE® (nab-paclitaxel) Development in Difficult-to-Treat Cancers

Cegedim Relationship Management gibt Mobile Intelligence 7 heraus, speziell entwickelt zur Steigerung der Geschäftseffizienz

Cegedim Relationship ManagementMobile Intelligence 7

Cegedim Relationship Management lança Mobile Intelligence 7, especificamente projetado para permitir maior eficácia comercial

Riassunto: Cegedim Relationship Management pubblica Mobile Intelligence 7, progettata specificamente per consentire una maggiore efficienza commerciale

 Pharma News - PharmiWeb
Mylan Launches Generic Version of Epivir® Film Coated Tablets in the UK and Italy, its First Generic ARV Launch in Europe

Healthcare Trust of America, Inc. Lists its Class A Common Stock on the NYSE

Tactio Deepens Its Healthcare Roots by Creating a Tactio Medical Advisory Board and Renaming itself as Tactio Health Group

Aperio ScanScope® Systems CE Marked as a Primary In Vitro Diagnostic Aid

Global Cardiovascular Disease Diagnostics Industry

 Pharma News - PR Newswire
ConsultantLive Announces Winners of Gold in Medical Diagnostic Game

US and European e-Prescription Systems Industry

Millennium Laboratories Provides Major Grant to WAKE UP! Campaign To Fight Prescription Drug Misuse and Abuse Among Teenagers

New STELARA® Five-Year Data Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis

Pradaxa® (dabigatran etexilate mesylate) U.S. Label Now Affirms Superior Reduction in Ischemic and Hemorrhagic Stroke Versus Warfarin in Patients with Non-Valvular Atrial Fibrillation
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

 PRWeb - Biotechnology
Photometrics® Launches Industry's Fastest, Most Sensitive 512x512...

Invention Eases Discomfort for Tonsillectomy Patients, Makes Procedure...

BioPharm Systems to Host Webinar on Streamlining a Global Life...

Study Says Bug Bombs Don't Work on Bed Bugs, Bed Bug Bully...

Albany CrossFit Announces $100,000 Fundraising Goal For St. Jude...
PRWeb - Pharmaceuticals
Latest IMV CT Survey Shows Hospitals Seek to Improve Productivity to...

National Medical Marijuana Business Conference Announced for 2012:...

Serene Launces An Advanced Master Data Management Solution For Media...

RJ Lee Group Scientists Publish Article on Nanotechnology in...

eTERA Consulting Names John Christly as Managing Consultant

 Scientific American
Lady Liaisons: Does Cheating Give Females an Evolutionary Advantage

Been There, Done That or Did I: Déjà Vu Found to Originate in Similar Scenes

Biosecurity Panel Flailed in Oversight of Mutant Bird Flu

Rhinoceros Undergoes Assisted Reproduction to Rescue Species from Extinction

White House Petitioned to Make Research Free to Access

 Sports - ESPN Basketball
Spurrier: Pay players '$3,500 to $4,000' a year

SEC football coaches differ on conference slate

Kentucky-Indiana series talks collapse again

Kansas City to host Big 12 tourney through '16

Father: Attention 'overwhelming' No. 1 recruit

Sports News - ESPN
New Big 12 commish Bowlsby anti pay for play

SEC presidents, ADs back best-teams playoff

4-star LB Smith to join Notre Dame's 2013 class

Report: SEC lenient on discipline for marijuana

Kansas LB Farley transferring to Northern Iowa

 Xconomy Life Sciences
Kineta, Playing for Bunt Singles, Builds a Biotech Company Without VC Bucks

FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed

Bayer Oncology Dubs ASCO Turning Point for Cancer Efforts

Recorded Future, GreenBytes, Seahorse, & More Boston-Area Dealmakers

Kona Medical Gets $30M To Zap High Blood Pressure With Ultrasound

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012